41 related articles for article (PubMed ID: 9189770)
1. Construction and biological characterization of an interleukin-12 fusion protein (Flexi-12): delivery to acute myeloid leukemic blasts using adeno-associated virus.
Anderson R; Macdonald I; Corbett T; Hacking G; Lowdell MW; Prentice HG
Hum Gene Ther; 1997 Jun; 8(9):1125-35. PubMed ID: 9189770
[TBL] [Abstract][Full Text] [Related]
2. Optimized expression and specific activity of IL-12 by directed molecular evolution.
Leong SR; Chang JC; Ong R; Dawes G; Stemmer WP; Punnonen J
Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1163-8. PubMed ID: 12529500
[TBL] [Abstract][Full Text] [Related]
3. Riboswitch-controlled IL-12 gene therapy reduces hepatocellular cancer in mice.
Düchs MJ; Kratzer RF; Vieyra-Garcia P; Strobel B; Schönberger T; Groß P; Aljayyoussi G; Gupta A; Lang I; Klein H; Morilla SM; Hopf S; Park J; Kreuz S; Klugmann M; Igney FH
Front Immunol; 2024; 15():1360063. PubMed ID: 38558809
[TBL] [Abstract][Full Text] [Related]
4. Defining the Basal and Immunomodulatory Mediator-Induced Phosphoprotein Signature in Pediatric B Cell Acute Lymphoblastic Leukemia (B-ALL) Diagnostic Samples.
Khanolkar A; Liu G; Simpson Schneider BM
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762241
[TBL] [Abstract][Full Text] [Related]
5. The chemical biology of IL-12 production
Koch PD; Pittet MJ; Weissleder R
RSC Chem Biol; 2020 Oct; 1(4):166-176. PubMed ID: 34458756
[TBL] [Abstract][Full Text] [Related]
6. IL-12 reprograms CAR-expressing natural killer T cells to long-lived Th1-polarized cells with potent antitumor activity.
Landoni E; Woodcock MG; Barragan G; Casirati G; Cinella V; Stucchi S; Flick LM; Withers TA; Hudson H; Casorati G; Dellabona P; Genovese P; Savoldo B; Metelitsa LS; Dotti G
Nat Commun; 2024 Jan; 15(1):89. PubMed ID: 38167707
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticle-mediated tumor cell expression of mIL-12 via systemic gene delivery treats syngeneic models of murine lung cancers.
Ahn HH; Carrington C; Hu Y; Liu HW; Ng C; Nam H; Park A; Stace C; West W; Mao HQ; Pomper MG; Ullman CG; Minn I
Sci Rep; 2021 May; 11(1):9733. PubMed ID: 33958660
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for IL-12 and IL-23 receptor sharing reveals a gateway for shaping actions on T versus NK cells.
Glassman CR; Mathiharan YK; Jude KM; Su L; Panova O; Lupardus PJ; Spangler JB; Ely LK; Thomas C; Skiniotis G; Garcia KC
Cell; 2021 Feb; 184(4):983-999.e24. PubMed ID: 33606986
[TBL] [Abstract][Full Text] [Related]
9. Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors.
Roybal KT; Williams JZ; Morsut L; Rupp LJ; Kolinko I; Choe JH; Walker WJ; McNally KA; Lim WA
Cell; 2016 Oct; 167(2):419-432.e16. PubMed ID: 27693353
[TBL] [Abstract][Full Text] [Related]
10. Tumor-infiltrating lymphocytes genetically engineered with an inducible gene encoding interleukin-12 for the immunotherapy of metastatic melanoma.
Zhang L; Morgan RA; Beane JD; Zheng Z; Dudley ME; Kassim SH; Nahvi AV; Ngo LT; Sherry RM; Phan GQ; Hughes MS; Kammula US; Feldman SA; Toomey MA; Kerkar SP; Restifo NP; Yang JC; Rosenberg SA
Clin Cancer Res; 2015 May; 21(10):2278-88. PubMed ID: 25695689
[TBL] [Abstract][Full Text] [Related]
11. The p40 subunit of interleukin (IL)-12 promotes stabilization and export of the p35 subunit: implications for improved IL-12 cytokine production.
Jalah R; Rosati M; Ganneru B; Pilkington GR; Valentin A; Kulkarni V; Bergamaschi C; Chowdhury B; Zhang GM; Beach RK; Alicea C; Broderick KE; Sardesai NY; Pavlakis GN; Felber BK
J Biol Chem; 2013 Mar; 288(9):6763-76. PubMed ID: 23297419
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of cellular immunotherapy in acute myeloid leukaemia.
Smits EL; Lee C; Hardwick N; Brooks S; Van Tendeloo VF; Orchard K; Guinn BA
Cancer Immunol Immunother; 2011 Jun; 60(6):757-69. PubMed ID: 21519825
[TBL] [Abstract][Full Text] [Related]
13. Tumor-specific CD8+ T cells expressing interleukin-12 eradicate established cancers in lymphodepleted hosts.
Kerkar SP; Muranski P; Kaiser A; Boni A; Sanchez-Perez L; Yu Z; Palmer DC; Reger RN; Borman ZA; Zhang L; Morgan RA; Gattinoni L; Rosenberg SA; Trinchieri G; Restifo NP
Cancer Res; 2010 Sep; 70(17):6725-34. PubMed ID: 20647327
[TBL] [Abstract][Full Text] [Related]
14. Cloning and characterization of an adenoviral vector for highly efficient and doxycycline-suppressible expression of bioactive human single-chain interleukin 12 in colon cancer.
Wulff H; Krieger T; Krüger K; Stahmer I; Thaiss F; Schäfer H; Block A
BMC Biotechnol; 2007 Jun; 7():35. PubMed ID: 17594499
[TBL] [Abstract][Full Text] [Related]
15. A vector expressing feline mature IL-18 fused to IL-1beta antagonist protein signal sequence is an effective adjuvant to a DNA vaccine for feline leukaemia virus.
O'Donovan LH; McMonagle EL; Taylor S; Bain D; Pacitti AM; Golder MC; McDonald M; Hanlon L; Onions DE; Argyle DJ; Jarrett O; Nicolson L
Vaccine; 2005 May; 23(29):3814-23. PubMed ID: 15893619
[TBL] [Abstract][Full Text] [Related]
16. An inducible caspase 9 safety switch for T-cell therapy.
Straathof KC; Pulè MA; Yotnda P; Dotti G; Vanin EF; Brenner MK; Heslop HE; Spencer DM; Rooney CM
Blood; 2005 Jun; 105(11):4247-54. PubMed ID: 15728125
[TBL] [Abstract][Full Text] [Related]
17. Effects of recombinant adenovirus-mediated expression of IL-2 and IL-12 in human B lymphoma cells on co-cultured PBMC.
Ebert O; Wilbert D; Buttgereit P; Ziske C; Flieger D; Schmidt-Wolf IG
Genet Vaccines Ther; 2004 Oct; 2(1):15. PubMed ID: 15485577
[TBL] [Abstract][Full Text] [Related]
18. In vitro co-stimulation with anti-CD28 synergizes with IL-12 in the generation of T cell immune responses to leukaemic cells; a strategy for ex-vivo generation of CTL for immunotherapy.
Orleans-Lindsay JK; Deru A; Craig JI; Prentice HG; Lowdell MW
Clin Exp Immunol; 2003 Sep; 133(3):467-75. PubMed ID: 12930376
[TBL] [Abstract][Full Text] [Related]
19. Improved antitumour immunity in murine neuroblastoma using a combination of IL-2 and IL-12.
Siapati KE; Barker S; Kinnon C; Michalski A; Anderson R; Brickell P; Thrasher AJ; Hart SL
Br J Cancer; 2003 May; 88(10):1641-8. PubMed ID: 12771934
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
